solventum thermo - Search News

Thermo Fisher Scientific, Solventum

Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion

Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion, sending the latter's shares up around 9%. The deal should allow Thermo to enter the filtration category in bioprocessing,

GEN · 2h

Thermo Fisher Scientific Agreed to Acquire Solventum’s Purification and Filtration Business

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

GlobalData on MSN · 2d

Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit

GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.

Solv, Q4 and EPS Beats

The Motley Fool on MSN · 10h

Solventum: Q4 EPS Beats, Cash Flow Dips

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures.

Zacks.com on MSN · 7h

SOLV Stock Down Despite Q4 Earnings & Revenues Beat Estimates

Solventum SOLV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.41, which beat the Zacks Consensus Estimate of $1.31 by 7.6%. The bottom line declined 35% year over year. GAAP EPS in the quarter was 17 cents,

StockStory.org on MSN · 1d

Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates

Healthcare solutions provider Solventum (NYSE:SOLV) reported in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per share was 7.8% above analysts’ consensus estimates.

MedCity News4d

Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment

Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs.

MM&M7h

Rx Rundown: Thermo Fisher Scientific, the CDC, Eli Lilly and more

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Trian ‘commends’ Solventum on Filtration unit sale, sees cost cut opportunities

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Thermo Fisher Scientific, Solventum

Solv, Q4 and EPS Beats

Trending now